P2RY12 and Sepsis: Previous studies suggested that platelet P2Y12 inhibition mitigates inflammation using rodent models of lipopolysaccharide-induced inflammation or CLP-sepsis with clopidogrel or P2Y12 receptor-deficient mice [9,10,22].